Approval for the Bayer Immuno 1(TM) PSA assay.  This device is indicated for the measurement of serum PSA in conjunction with digital rectal exam (DRE) as an aid in the detection of prostate cancer in men aged 50 years and older.  This assay is further indicated as an aid in the management (monitoring) of prostate cancer patients.